Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)

NCT00424086 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Inactivated seasonal influenza vaccine (split virus, vero cell derived)
BIOLOGICAL: Inactivated seasonal influenza vaccine (split virus, egg derived) [licensed control vaccine]

Sponsor

Alachua Government Services, Inc.